Table 2.
Association between erectile dysfunction medication and serodiscordant insertive condomless anal sex, by partner type, among sexually active MSM with HIV diagnosis for at least 12 months receiving medical care in the United Sates (n=4,465), Medical Monitoring Project, 2009–2012
| EDM prescription | With a main partner (n=4462)a | With a casual partner (n=4456)b | ||||
|---|---|---|---|---|---|---|
| Weighted % (95% CI) | Crude PR (95% CI) | Adjustedc PR (95% CI) | Weighted % (95% CI) | Crude PR (95% CI) | Adjustedd PR (95% CI) | |
| No | 6 (5–7) | referent | referent | 6 (5–7) | referent | referent |
| Yes | 6 (4–8) | 0.91 (0.64–1.29) | 1.04 (0.74–1.47) | 9 (6–12) | 1.45 (1.05–1.99) | 1.38 (1.01–1.88) |
MSM, men who have sex with men; CI, confidence interval; EDM, erectile dysfunction medication; PR, prevalence ratio.
a
Missing n=3.
b
Missing n=9.
c
Adjusted for age and illicit drug use before or during sex.
d
Adjusted for illicit drug use before or during sex.